Skip Ribbon Commands
Skip to main content
Menu

Clinical Trials & Research

Dementia, Parkinson's disease and many other neurological conditions currently have no cure. Our researchers are working hard to change that but they need your help to succeed.

By taking part in clinical trials and research projects, you can help us better understand the brain, improve treatments for disabling conditions and help your loved ones enjoy better brain health in the future. 


        

NeusLink issue 14 cover.PNG     

Peripheral Neuropathy

NNI is conducting a study to evaluate corneal nerve changes and biomarkers in patients with peripheral neuropathy.

What the study involves:

  • 1 visit to Singapore National Eye Centre
  • Questionnaires and simple neurological assessment
  • Corneal nerve imaging
  • Tears and blood collection

Who is eligible?

  • Age ≥ 21 years old
  • Neuropathy related to diabetes or chronic inflammatory demyelinating polyneuropathy (CIDP)
  • No previous corneal abnormalities, recent eye surgery or infection
  • Not pregnant

Contact

Research Coordinator
NeuropathyStudies@nni.com.sg

Click for details

 


        

NeusLink issue 14 cover.PNG     

Cognitive Effects of COVID-19

NNI is studying the long-term impact of COVID-19 on memory and brain function, and resilience and recovery in patients with COVID-19 infection.

What the study involves:

  • 2 - 4 visits over 15 months (depending)
  • Cognitive assessments and questionnaires

Eligible participants will additionally be offered enhanced screening:

  • Magnetic Resonance Imaging (MRI) brain scan
  • Smell and taste test
  • Blood sample collection

Who is eligible?

  • Aged 21 years old and above
  • Previous COVID-19 infection up to 12 months ago, with any of the following symptoms (may be recovered):
    • Loss of smell and/or loss of taste
    • Pneumonia or severe symptoms requiring breathing support
  • Asymptomatic participants will also be recruited

Contact

Christine Lock
christine_lock_hm@nni.com.sg / 6357 7616

Pearl Sim
pearl.simzq@ntu.edu.sg
Mon to Fri , 8.30am - 6pm

Click for details

 


        

NeusLink issue 14 cover.PNG     

Neptune Study

NNI is investigating whether smartwatches and mobile apps can help one achieve better treatment effect, to optimise Parkinson's motor symptom control.

Who is eligible?

  • Aged 21 to 85 years old
  • Diagnosed with Primary/Idiopathic Parkinson's
  • Stage 2 or above and is currently on treatment
  • Experience symptoms in the last four weeks
  • Have reasonable vision/hearing (lenses or hearing aid are permitted)
  • Able to provide written informed consent

Contact

Marcus Glenn Wong
marcus_glenn_wong@nni.com.sg / 6357 2618

Click for details